International Patent: NUCLEIC ACIDS COMPRISING LOCKED NUCLEIC ACIDS (LNA) FOR INHIBITING GENE EXPRESSION IN A CELL

GENEVA, July 2 -- SILENCE THERAPEUTICS GMBH filed a patent application (EP2025/052611) for “NUCLEIC ACIDS COMPRISING LOCKED NUCLEIC ACIDS (LNA) FOR INHIBITING GENE EXPRESSION IN A CELL”. With publication no. WO/2026/130744, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....